As AI moves into increasingly consequential applications, the next challenge is not what these systems can do, but whether people can trust the answers they provide.
Proteogenomic analysis of brain tumors identified potential treatment targets and prognostic markers that differed across age, developmental stage, and sex.
Transpher A data show a 23.5-point cognitive advantage over natural history, supporting the first-ever FDA approval for pediatric patients with MPS IIIA
Final PAPILLON data show amivantamab-vmjw plus chemotherapy reaches 34 months median OS, the longest reported in this historically treatment-resistant NSCLC subtype
CAR T has transformed treatment for some blood cancers, but manufacturing and healthcare system constraints still prevent many eligible patients from receiving it.
Explore how surface plasmon resonance can reveal binding kinetics, epitope relationships, and receptor interactions to guide antibody lead optimization.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.